Search
for
Sort by
Research 751–780 of 1000+
- Hormonal prevention of prostate cancer
- Hypothyroidism in Thyroid Carcinoma Follow-up: Orlistat May Inhibit the Absorption of Thyroxine
- Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy
- Rash from EGFR inhibitors: Opportunities and challenges for palliation
- Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study
- Pilomatrix Carcinoma: Report of Two Cases of the Head and Review of the Literature
- Association between male pattern baldness and prostate disease: A meta-analysis
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- Hypertrichosis lanuginosa acquisita following cytotoxic chemotherapy
- Effect of finasteride on prostate-specific antigen
- Hair Growth After Gefitinib Treatment
- The effects of low-dose radiation therapy in patients with mild-to-moderate Alzheimer's dementia: an interim analysis of a pilot study
- Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases
- Dual blockage of P-cadherin and c-Met synergistically inhibits the growth of head and neck cancer
- A plain language summary of quality of life with sacituzumab govitecan treatment in the TROPiCS-02 study in participants with breast cancer (HR-positive/HER2-negative)
- Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention
- A cornerstone of hematological science
- Male alopecia, finasteride, and cancer risk
- How not to detect prostate cancer
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- Docetaxel.
- Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.
- Qualitative and Quantitative Assessment of Taste and Smell Changes in Patients Undergoing Chemotherapy for Breast Cancer or Gynecologic Malignancies
- Pathobiology of chemotherapy-induced hair loss
- A Review on the Clinical Utility of PSA in Cancer Prostate
- Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer
- Permanent alopecia after cranial irradiation: Dose–response relationship